Highlighting Insight Gained from the Development of the First Generation of Anti-Amyloids & Efforts to Bolster Innovation in New Modalities & Targets
Time: 9:00 am
day: Conference Day One AM
Details:
- Reviewing what we’ve learned from the first generation of anti-amyloids and where extra effort is needed to enhance their RoA and manage burdens of ARIA
- Exploring gaps in our understanding of ARIA that may warrant additional work
- Future directions for the development of new modalities and targets beyond amyloid to address unmet patient needs
